Dr. Ansar Khan of Fremont Urology Health Center Offers Patients Innovative UroLift® System for Patients Suffering Symptoms of Enlarged Prostate

Share Article

Dr. Ansar Khan of Fremont Urology will present a discussion about enlarged prostate and the UroLift® System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men 50 years of age or older. The Community Health Talk will take place on November 29th at Fremont Hospital from 6:30-7:30pm.

Our hospital system is committed to providing patients with the highest quality, most effective options to address their urology needs.

Dr. Ansar Khan of Fremont Urology, today announced that he will present a discussion about enlarged prostate and the UroLift® System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men 50 years of age or older. Cleared by the U.S. Food and Drug Administration in 2013, the UroLift System is designed to relieve symptoms caused by an enlarged prostate, while preserving sexual function. The Community Talk will be held at Fremont Hospital on November 29th from 6:30 – 7:30pm.

“Our hospital system is committed to providing patients with the highest quality, most effective options to address their urology needs,” said Dr. Khan, MD. “The UroLift System has an excellent safety profile and provides men suffering from an enlarged prostate a beneficial first-line treatment alternative to drug therapy or more invasive surgery. Importantly, the UroLift System provides fast and meaningful relief from BPH symptoms, improving overall quality of life for our patients.”

The UroLift System permanent implants, delivered during a minimally-invasive procedure, act like window curtain tie-backs to hold the lobes of an enlarged prostate open. Patients recover from the procedure quickly, and return to their normal routines with minimal downtime.

Data from clinical trials showed that patients receiving UroLift implants reported rapid symptomatic improvement, improved urinary flow rates, and sustained sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.

The Community Health talk will be held in the amphitheater of Fremont Hospital, 450 East 23rd Street, 3rd floor, Park Plaza. Space is limited, so attendees are encouraged to RSVP at (855) 564-9722. Partners and guests are invited to attend. A light meal and refreshments will be provided.

About BPH Treatment

More than 500 million aging men worldwide have an enlarged prostate. Medication is often the first line therapy but relief can be inadequate and temporary. Side effects of treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts or ablates prostate tissue to open the blocked urethra. While current surgical options, such as the 'gold standard' surgery, Transurethral Resection of the Prostate (TURP), can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation (dry orgasm).

About UroLift

The UroLift System provides an alternative to tissue removing surgery for the treatment of an enlarged prostate. Performed through the urethra, a urologist uses the UroLift System to push aside the obstructive prostate lobes and positions small, tailored permanent UroLift implants to hold the prostate lobes in the retracted position. This opens the urethra while leaving the prostate intact. Adverse reactions associated with UroLift System treatment were comparable to other minimally invasive surgical therapies as well as standard cystoscopy. The most common adverse events reported during the study included pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate, and the inability to control urine because of an urgent need to urinate. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.

About Fremont Urology

Urology Health Center, with offices in Fremont and Omaha, Nebraska, offers diagnosis and treatment of all urological condition and disorders. The mission of Urology Health Center is to provide our patients with the highest level of specialized care in a patient friendly environment. The offices can be reached at 402-727-5000 (Fremont) or 402-391-0705 (Omaha).

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Amy Cramer
Nicole Osmer Communications
+1 (650) 391-3714
Email >
Visit website